Head of Endocrinology Department, University of Medicine and Pharmacy, Ho Chi Minh City 72000, Vietnam.
Department of Endocrinology, University of Medicine and Pharmacy, Ho Chi Minh City 72000, Vietnam.
Int J Environ Res Public Health. 2020 Feb 3;17(3):937. doi: 10.3390/ijerph17030937.
Digital technologies are gaining an important role in the management of patients with diabetes. We assessed clinical outcomes and user satisfaction of incorporating a digital diabetes care system in diabetes clinics of a developing country. The system integrated a wireless blood glucose monitor that communicates data to any smartphone utilizing a patented acoustic data transfer method, a mobile-app, and cloud-based software that stores, analyzes, and presents data. Five hospital endocrinology clinics in Vietnam sequentially recruited all patients willing to join the study, providing they had a smartphone and access to internet connectivity. Face-to-face visits were conducted at baseline and at 12 weeks, with monthly digital visits scheduled in the interim and additional digital visits performed as needed. HbA1c levels were measured at baseline and at 12 weeks (±20 days). The study included 300 patients of whom 279 completed the evaluation. Average glucose levels declined from 170.4 ± 64.6 mg/dL in the first 2 weeks to 150.8 ± 53.2 mg/dL in the last 2 weeks ( = 221; < 0.001). HbA1c levels at baseline and 12 weeks declined from 8.3% ± 1.9% to 7.6% ± 1.3% ( = 126; < 0.001). The digital solution was broadly accepted by both patients and healthcare professionals and improved glycemic outcomes. The durability, scalability, and cost-effectiveness of this approach merits further study.
数字技术在糖尿病患者管理中发挥着重要作用。我们评估了将数字糖尿病护理系统纳入发展中国家糖尿病诊所的临床结果和用户满意度。该系统集成了一个无线血糖监测器，可利用专利声数据传输方法将数据传输到任何智能手机，还包括一个移动应用程序和基于云的软件，用于存储、分析和呈现数据。越南的五家医院内分泌科诊所连续招募了所有愿意参加研究的患者，前提是他们有智能手机并能访问互联网。在基线和 12 周时进行面对面访视，在此期间每月进行数字访视，并根据需要进行额外的数字访视。在基线和 12 周时测量 HbA1c 水平（±20 天）。该研究纳入了 300 名患者，其中 279 名完成了评估。平均血糖水平从第 1 至第 2 周的 170.4 ± 64.6mg/dL 下降到第 11 至第 12 周的 150.8 ± 53.2mg/dL（ = 221； < 0.001）。HbA1c 水平在基线和 12 周时从 8.3%±1.9%下降到 7.6%±1.3%（ = 126； < 0.001）。该数字解决方案得到了患者和医疗保健专业人员的广泛认可，并改善了血糖控制结果。这种方法的耐久性、可扩展性和成本效益值得进一步研究。
